Literature DB >> 18428004

Strength, physical activity, and fasciculations in patients with ALS.

Farrah J Mateen1, Eric J Sorenson, Jasper R Daube.   

Abstract

Fasciculations are a nearly universal feature in people with amyotrophic lateral sclerosis (ALS). The prognostic value of fasciculations remains uncertain. Twenty-four patients with ALS were evaluated for the effects of atrophy, limb weakness, disease duration, and physical activity on fasciculation frequency (as measured by surface electromyography and clinical counting). Variables were compared by multiple linear regression. As strength of the limb deteriorated, the number of fasciculations in the same limb increased, as long as physical activity was maintained or increased. Fasciculation frequency was not associated with the duration of ALS (r = 0.22; p = 0.30) and was independent of the degree of limb weakness (p>0.05) and limb atrophy (p>0.05). No prediction of disease duration could be made based on fasciculation frequency alone. Fasciculations therefore appear to have diagnostic, but not prognostic, utility in the care of people with ALS.

Entities:  

Mesh:

Year:  2008        PMID: 18428004     DOI: 10.1080/17482960701855864

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  3 in total

1.  The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study.

Authors:  Femke Nijboer; Niels Birbaumer; Andrea Kübler
Journal:  Front Neurosci       Date:  2010-07-21       Impact factor: 4.677

2.  SPiQE: An automated analytical tool for detecting and characterising fasciculations in amyotrophic lateral sclerosis.

Authors:  J Bashford; A Wickham; R Iniesta; E Drakakis; M Boutelle; K Mills; C Shaw
Journal:  Clin Neurophysiol       Date:  2019-04-19       Impact factor: 3.708

3.  The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review.

Authors:  J Bashford; K Mills; C Shaw
Journal:  Clin Neurophysiol       Date:  2019-12-27       Impact factor: 3.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.